Formulation and evaluation of ketorolac tromethamine-eudragit solid dispersions of potential sustained release properties

• In: Industrial Pharmacy- Posters
• At: Istanbul (Turkey) (2009)
• Type: Poster
• Poster code: IPS-P-012
• By: IBRAHIM, Mohamed (Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Al-Azh, Assiut, Egypt)
• Co-author(s): Amin, Mohamed (Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Al-Azh, ASSIUT, Egypt)
  Fetih, Gehan (Department of Pharmaceutics, Faculty of Pharmacy, Assiut University, ASSIUT, Egypt)
  Abou Ela, Amal (Department of Pharmaceutics, Faculty of Pharmacy, Assiut University, ASSIUT, Egypt)
  
• Abstract:

  Ketorolac tromethamine (KT) is a nonsteroidal anti-inflammatory drug having a half-life around 6 hours. Formulation of KT in a sustained released form can be beneficial not only in reducing dose frequency but also in minimizing the severity of KT adverse reactions.
  
  This study aimed to formulate sustained release KT by preparing solid dispersion..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login